drugset / Trial / NCT01501890
Progesterone for First Trimester Vaginal Bleeding
Withdrawn
Soroka University Medical Center
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to investigate whether treatment with progesterone for patients with first trimester vaginal bleeding will alter the rates of obstetrical complications and adverse pregnancy outcomes.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-12
- Completion
- 2014-09
Outcome
Outcome not reported
Stopped: “never started”
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | dihydroxyprogesterone caproate | Unknown | 250 mg | Intramuscular |